| http://www.w3.org/ns/prov#value | - non-porous, or gelatinous material, including membranes, such as sialastic membranes, or fibers.In an embodiment where the therapeutic is a nucleic acid encoding an A-chain peptide or analog therapeutic the nucleic acid is administered in vivo to promote expression of its encoded A-chain peptide by constructing it as part of an appropriate nucleic acid expression vector and administering it so th
|
